Literature DB >> 3966408

Epidemiology of congestive heart failure.

W M Smith.   

Abstract

Despite the paucity of epidemiologic work on congestive heart failure (CHF), the salient features of the natural course of cardiac failure are understood. The estimated 1983 incidence of CHF in the United States was 214,000 men and 184,000 women. The estimate of prevalence was 2.3 million persons, with a remarkable increase with advancing age and higher rates in men than women at all ages. Overt heart disease plus age are the principal determinants of the incidence of CHF. Nearly 90% of patients with CHF have systemic hypertension or coronary heart disease, or both, as the antecedent underlying condition. Diabetes mellitus increases the risk of CHF at all ages, particularly in women and those treated with insulin. The prognosis after diagnosis of CHF is grim and is related to the degree of myocardial dysfunction. The challenge is to develop more effective drugs not only for the management of overt CHF, but also for the prevention of its progression.

Entities:  

Mesh:

Year:  1985        PMID: 3966408     DOI: 10.1016/0002-9149(85)90789-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

Authors:  R S McKelvie; C R Benedict; S Yusuf
Journal:  BMJ       Date:  1999-05-22

Review 2.  Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks.

Authors:  U Ravens; M Wehr
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

3.  The influence of decisions made by developers on health status questionnaire content.

Authors:  C J O'Leary; P W Jones
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

4.  Introduction.

Authors:  Walter Bleifeld
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 5.  Early intervention in heart failure.

Authors:  M A Creager
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 6.  Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure.

Authors:  C Pappone; G Vicedomini; A Salvati; C Meloni; W Haddad; R Aviv; Y Mika; N Darvish; Y Kimchy; I Shemer; Y Snir; D Pruchi; S A Ben-Haim; I Kronzon
Journal:  Heart Fail Rev       Date:  2001-01       Impact factor: 4.214

7.  Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model.

Authors:  B A van Hout; G Wielink; G J Bonsel; F F Rutten
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

8.  QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure.

Authors:  L Bode-Schnurbus; D Böcker; M Block; R Gradaus; A Heinecke; G Breithardt; M Borggrefe
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

9.  Left ventricular pacing improves haemodynamic variables in patients with heart failure with a normal QRS duration.

Authors:  M S Turner; R A Bleasdale; C E Mumford; M P Frenneaux; J A Morris-Thurgood
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

10.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.